ISTA PHARMACEUTICALS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-06-06: Reporting owner ANIDO VICENTE JR; Form 4; Security Stock Appreciation Right; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-30: Reporting owner ANIDO VICENTE JR; Form 4; Security Stock Appreciation Right; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-06-06 | ANIDO VICENTE JR Director, Officer (President & CEO) | 4 | Stock Appreciation Right Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −172,775 0 owned after | $3.75 exercise price | 2012-06-15 | |
| 2011-11-30 | ANIDO VICENTE JR Director, Officer (President & CEO) | 4 | Stock Appreciation Right Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +172,775 172,775 owned after | $3.75 | 2011-12-02 |